600200 江苏吴中
已退市 12-30 09:30:00
资讯
新帖
简况
江苏吴中(600200)投资者索赔案已启动债权申报工作
市场资讯 · 08-20
江苏吴中(600200)投资者索赔案已启动债权申报工作
江苏吴中(600200)、高鸿股份(000851)投资者索赔案均再提交法院立案
市场资讯 · 06-18
江苏吴中(600200)、高鸿股份(000851)投资者索赔案均再提交法院立案
事关艾塑菲童颜针母公司!爱美客、江苏吴中先后回应
中新经纬 · 2025-03-11
事关艾塑菲童颜针母公司!爱美客、江苏吴中先后回应
江苏吴中03月10日主力净流入539万元 散户资金抛售
市场透视 · 2025-03-10
江苏吴中03月10日主力净流入539万元 散户资金抛售
江苏吴中(600200.SH):硫酸阿米卡星注射液通过仿制药一致性评价
智通财经 · 2025-03-07
江苏吴中(600200.SH):硫酸阿米卡星注射液通过仿制药一致性评价
江苏吴中最新公告:硫酸阿米卡星注射液通过仿制药一致性评价
证券之星 · 2025-03-07
江苏吴中最新公告:硫酸阿米卡星注射液通过仿制药一致性评价
江苏吴中03月07日遭主力抛售5481万元
市场透视 · 2025-03-07
江苏吴中03月07日遭主力抛售5481万元
江苏吴中称公司各项经营活动和业务均正常开展
北京商报 · 2025-03-05
江苏吴中称公司各项经营活动和业务均正常开展
江苏吴中03月05日主力净流入1886万元 散户资金抛售
市场透视 · 2025-03-05
江苏吴中03月05日主力净流入1886万元 散户资金抛售
3月3日江苏吴中(600200)龙虎榜数据:机构净卖出6396.71万元,北向资金净卖出2201.31万元
证券之星 · 2025-03-03
3月3日江苏吴中(600200)龙虎榜数据:机构净卖出6396.71万元,北向资金净卖出2201.31万元
3月3日江苏吴中跌5.93%,农银医疗保健股票基金重仓该股
证券之星 · 2025-03-03
3月3日江苏吴中跌5.93%,农银医疗保健股票基金重仓该股
江苏吴中03月03日遭主力抛售7917万元
市场透视 · 2025-03-03
江苏吴中03月03日遭主力抛售7917万元
PDRN复合溶液临床入组完成,江苏吴中有望再添大单品,抢占再生医美赛道先机
证券之星 · 2025-03-03
PDRN复合溶液临床入组完成,江苏吴中有望再添大单品,抢占再生医美赛道先机
异动快报:江苏吴中(600200)3月3日10点2分触及跌停板
证券之星 · 2025-03-03
异动快报:江苏吴中(600200)3月3日10点2分触及跌停板
江苏吴中收盘下跌10.05%,最新市净率2.87,总市值51.63亿元
金融界 · 2025-02-28
江苏吴中收盘下跌10.05%,最新市净率2.87,总市值51.63亿元
加载更多
公司概况
公司名称:
江苏吴中医药发展股份有限公司
所属行业:
医药制造业
上市日期:
1999-04-01
主营业务:
江苏吴中医药发展股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是大容量注射剂、小容量注射剂、粉针剂、冻干粉针剂、硬胶囊剂、颗粒剂、片剂(含抗肿瘤药)、口服溶液剂、滴丸剂、乳剂和原料药(含抗肿瘤药)。近年来,吴中医药发展良好,规模日益扩大,经济效益持续增长,被评定为高新技术企业、江苏省专精特新中小企业、江苏省创新型企业、江苏省管理创新优秀企业、江苏省守合同重信用企业等,并入选苏州市生物医药产业首批潜力地标培育企业名单和苏州市第三批自主品牌大企业和领军企业先进技术研究院建设企业名单。
发行价格:
7.75
{"stockData":{"symbol":"600200","market":"SH","secType":"STK","nameCN":"江苏吴中","latestPrice":0.29,"timestamp":1767058140000,"preClose":0.29,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":-0.0874,"marketStatus":"已退市","change":0,"latestTime":"12-30 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.0874,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":7,"adr":0,"adjPreClose":0.29,"symbolType":"stock","openAndCloseTimeList":[[1788226200000,1788233400000],[1788238800000,1788246000000]],"highLimit":0.32,"lowLimit":0.26,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":710879480,"isCdr":false,"pbRate":0,"roa":"--","roe":"--","epsLYR":0.1,"committee":0,"marketValue":0,"turnoverRate":0,"status":4,"floatMarketCap":0},"requestUrl":"/m/hq/s/600200","defaultTab":"news","newsList":[{"id":"2660440375","title":"江苏吴中(600200)投资者索赔案已启动债权申报工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440375","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660440375?lang=zh_cn&edition=full","pubTime":"2026-08-20 13:25","pubTimestamp":1787203500,"startTime":"0","endTime":"0","summary":"2025年11月25日晚,江苏吴中公告收到证监会下发的《行政处罚决定书》,经查明,江苏吴中存在以下违法事实:一、未如实披露实际控制人,2018年至2023年年度报告存在虚假记载。专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为,在2019年4月20日到2025年2月27日之间买入江苏吴中股票,并且在2025年2月27日后卖出或继续持有股票的投资者,目前还可发起索赔。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-08-20/doc-ininxvfr6733914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0060","BK0188","BK0028","600200","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644047267","title":"江苏吴中(600200)、高鸿股份(000851)投资者索赔案均再提交法院立案","url":"https://stock-news.laohu8.com/highlight/detail?id=2644047267","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644047267?lang=zh_cn&edition=full","pubTime":"2026-06-18 18:02","pubTimestamp":1781776920,"startTime":"0","endTime":"0","summary":" 2026年6月17日,上海久诚律师事务所股票索赔律师许峰代理的江苏吴中投资者索赔案再向苏州市中级人民法院提交一次立案,此前已多次提交立案,目前正在等待法院的下一步安排,律师团队同步还在继续推进后续案件的立案工作,还在继续接受其他投资者的索赔委托。 2025年11月25日晚,江苏吴中公告收到证监会下发的《行政处罚决定书》,经查明,江苏吴中存在以下违法事实:","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-06-18/doc-inicvrtm6418112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0137","BK0012","BK0060","BK0115","BK0164","600200","BK0209","BK0188","000851","BK0067","BK0010","BK0028","BK0239","BK0055","BK0103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518711193","title":"事关艾塑菲童颜针母公司!爱美客、江苏吴中先后回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2518711193","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518711193?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:46","pubTimestamp":1741682774,"startTime":"0","endTime":"0","summary":"同时,公告显示,对于剩余股权交易安排,爱美客拟于REGEN交割完成18个月后,收购其剩余的15%股权。11日,爱美客向中新经纬确认,本次交易是公司上市以来首次对境外公司进行控股收购。不过,目前,AestheFill在中国大陆地区的销售代理权在另一家上市公司江苏吴中手中。AestheFill又称童颜针,江苏吴中曾在公告中介绍,该产品用于注射到面部真皮深层,以纠正中重度鼻唇沟皱纹。爱美客尚未完成对REGEN的收购,江苏吴中的代理权暂时没有受到影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111808119641390c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111808119641390c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0251","600200","BK0239","BK0060","BK0012","300896","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518292341","title":"江苏吴中03月10日主力净流入539万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518292341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518292341?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:19","pubTimestamp":1741591148,"startTime":"0","endTime":"0","summary":"03月10日, 江苏吴中股价涨1.77%,报收6.32元,成交金额5.22亿元,换手率11.62%,振幅6.12%,量比0.65。江苏吴中今日主力资金净流入539万元,上一交易日主力净流出5481万元。该股近5个交易日下跌7.33%,主力资金累计净流出2.42亿元;近20日主力资金累计净流出5.36亿元,其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310154058a2699279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310154058a2699279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0012","BK0239","BK0188","BK0060","600200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517516486","title":"江苏吴中(600200.SH):硫酸阿米卡星注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2517516486","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517516486?lang=zh_cn&edition=full","pubTime":"2025-03-07 19:30","pubTimestamp":1741347038,"startTime":"0","endTime":"0","summary":"智通财经APP讯,江苏吴中 发布公告,近日,公司全资子公司江苏吴中医药集团有限公司下属分支机构江苏吴中医药集团有限公司苏州制药厂收到了国家药品监督管理局核准签发的关于“硫酸阿米卡星注射液”的《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。由于本品对多数氨基糖苷类钝化酶稳定,故尤其适用于治疗革兰阴性杆菌对卡那霉素、庆大霉素或妥布霉素耐药菌株所致的严重感染。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0060","BK0028","BK0239","BK0188","600200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517488643","title":"江苏吴中最新公告:硫酸阿米卡星注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2517488643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517488643?lang=zh_cn&edition=full","pubTime":"2025-03-07 18:51","pubTimestamp":1741344667,"startTime":"0","endTime":"0","summary":"江苏吴中公告称,公司全资子公司江苏吴中医药集团有限公司苏州制药厂收到国家药品监督管理局核准签发的关于“硫酸阿米卡星注射液”的《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。硫酸阿米卡星注射液适用于敏感革兰阴性杆菌与葡萄球菌属所致严重感染,如菌血症或败血症、细菌性心内膜炎等。公司硫酸阿米卡星注射液项目已投入研发费用约为479.38万元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700036229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0188","BK0028","600200","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517410511","title":"江苏吴中03月07日遭主力抛售5481万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517410511?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:23","pubTimestamp":1741332186,"startTime":"0","endTime":"0","summary":"03月07日, 江苏吴中股价跌2.51%,报收6.21元,成交金额5.48亿元,换手率12.33%,振幅5.49%,量比0.79。江苏吴中今日主力资金净流出5481万元,上一交易日主力净流出2917万元。该股近5个交易日下跌14.34%,主力资金累计净流出3.27亿元;近20日主力资金累计净流出5.51亿元,其中净流出天数为19日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165107a263d7f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165107a263d7f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0060","600200","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517743912","title":"江苏吴中称公司各项经营活动和业务均正常开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2517743912","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517743912?lang=zh_cn&edition=full","pubTime":"2025-03-05 21:44","pubTimestamp":1741182240,"startTime":"0","endTime":"0","summary":"北京商报讯(记者丁宁)3月5日晚间,江苏吴中(600200)发布公告称,目前,公司各项经营活动和业务均正常开展。截至公告披露日,中国证监会的调查尚在进行中,公司尚未收到就上述立案调查事项的结论性意见或决定。在立案调查期间,公司积极配合中国证监会的相关调查工作。公司将每周披露1次风险性提示公告,说明立案调查进展情况。江苏吴中表示,若后续经中国证监会行政处罚认定的事实,触及《上海证券交易所股票上市规则》规定的重大违法强制退市情形,公司股票存在重大违法强制退市的风险。(文章来源:北京商报)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305214810989d3ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305214810989d3ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","600200","BK0060","BK0239","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517961872","title":"江苏吴中03月05日主力净流入1886万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961872","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517961872?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:18","pubTimestamp":1741159133,"startTime":"0","endTime":"0","summary":"03月05日, 江苏吴中股价涨3.86%,报收6.46元,成交金额6.81亿元,换手率14.90%,振幅4.98%,量比1.39。江苏吴中今日主力资金净流入1886万元,上一交易日主力净流出1.83亿元。该股近5个交易日下跌27.90%,主力资金累计净流出3.10亿元;近20日主力资金累计净流出4.73亿元,其中净流出天数为18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305153528abe91d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305153528abe91d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","600200","BK0012","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516846683","title":"3月3日江苏吴中(600200)龙虎榜数据:机构净卖出6396.71万元,北向资金净卖出2201.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516846683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516846683?lang=zh_cn&edition=full","pubTime":"2025-03-03 17:17","pubTimestamp":1740993436,"startTime":"0","endTime":"0","summary":"此次是近5个交易日内第3次上榜。截至2025年3月3日收盘,江苏吴中报收于6.82元,下跌5.93%,换手率28.88%,成交量205.27万手,成交额13.52亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出6396.71万元,北向资金合计净卖出2201.31万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300023165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600200","BK0028","BK0012","BK0239","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516499504","title":"3月3日江苏吴中跌5.93%,农银医疗保健股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516499504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516499504?lang=zh_cn&edition=full","pubTime":"2025-03-03 16:19","pubTimestamp":1740989965,"startTime":"0","endTime":"0","summary":"证券之星消息,3月3日江苏吴中跌5.93%创60日新低,收盘报6.82元,换手率28.88%,成交量205.27万手,成交额13.52亿元。重仓江苏吴中的公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级4家;过去90天内机构目标均价为12.7。根据2024基金年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为农银医疗保健股票。该公募基金现任基金经理为梦圆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300020783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600200","BK0060","BK0028","BK0239","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516950633","title":"江苏吴中03月03日遭主力抛售7917万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516950633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516950633?lang=zh_cn&edition=full","pubTime":"2025-03-03 15:18","pubTimestamp":1740986314,"startTime":"0","endTime":"0","summary":"03月03日, 江苏吴中股价跌5.93%,报收6.82元,成交金额13.52亿元,换手率28.88%,振幅9.52%,量比21.28。江苏吴中今日主力资金净流出7917万元,上一交易日主力净流出2719万元。该股近5个交易日下跌24.97%,主力资金累计净流出1.79亿元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出3.17亿元,其中净流出天数为19日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303153114a25cae77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303153114a25cae77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0060","BK0239","BK0028","600200","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516629527","title":"PDRN复合溶液临床入组完成,江苏吴中有望再添大单品,抢占再生医美赛道先机","url":"https://stock-news.laohu8.com/highlight/detail?id=2516629527","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516629527?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:05","pubTimestamp":1740967559,"startTime":"0","endTime":"0","summary":"PDRN凭借高安全性、组织修复及胶原再生等功效,成为再生医美领域的明星成分。随着PDRN溶液上市进程的步步推进,江苏吴中在高端医美赛道的竞争力也将进一步增强,发展未来可期。PDRN复合溶液获进展,具备爆品潜质证券之星获悉,江苏吴中的PDRN复合溶液产品已于1月底完成全部临床受试者入组,预计于2025年下半年提交上市申请,2026年内有望获批上市。目前,江苏吴中已有三个二类械产品获得江苏省药品监督管理局颁发的《医疗器械注册证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025030300005445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","600200","BK0060","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516527599","title":"异动快报:江苏吴中(600200)3月3日10点2分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2516527599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516527599?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:05","pubTimestamp":1740967535,"startTime":"0","endTime":"0","summary":"证券之星3月3日盘中消息,10点2分江苏吴中触及跌停板。目前价格6.53,下跌9.93%。其所属行业化学制药目前上涨。领涨股为赛托生物。该股为创新药,医药,新冠病毒防治概念热股,当日创新药概念上涨1.92%,医药概念上涨1.89%,新冠病毒防治概念上涨1.87%。2月28日的资金流向数据方面,主力资金净流出2092.57万元,占总成交额60.48%,游资资金净流入697.23万元,占总成交额20.15%,散户资金净流入1395.34万元,占总成交额40.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300005203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","BK0028","BK0012","600200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514034716","title":"江苏吴中收盘下跌10.05%,最新市净率2.87,总市值51.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514034716","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514034716?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:10","pubTimestamp":1740741028,"startTime":"0","endTime":"0","summary":"2月28日,江苏吴中今日收盘7.25元,下跌10.05%,最新市净率2.87,总市值51.63亿元。截至2024年三季报,共有6家机构持仓江苏吴中,其中基金6家,合计持股数1058.36万股,持股市值0.99亿元。最新一期业绩显示,2024年三季报,公司实现营业收入16.47亿元,同比9.58%;净利润4508.06万元,同比311.54%,销售毛利率34.54%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28191048462300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600200","BK0012","BK0188","BK0239","BK0028","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788297298491,"stockEarnings":[],"compareEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.0385},{"period":"3month","weight":-0.0255},{"period":"6month","weight":-0.0313},{"period":"1year","weight":0.0269},{"period":"ytd","weight":0.0028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏吴中医药发展股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"67406人(较上一季度减少1.99%)","perCapita":"10546股","listingDate":"1999-04-01","address":"江苏省苏州市吴中区东方大道988号","registeredCapital":"71087万元","survey":" 江苏吴中医药发展股份有限公司的主营业务是药品研发、生产和销售。公司的主要产品是大容量注射剂、小容量注射剂、粉针剂、冻干粉针剂、硬胶囊剂、颗粒剂、片剂(含抗肿瘤药)、口服溶液剂、滴丸剂、乳剂和原料药(含抗肿瘤药)。近年来,吴中医药发展良好,规模日益扩大,经济效益持续增长,被评定为高新技术企业、江苏省专精特新中小企业、江苏省创新型企业、江苏省管理创新优秀企业、江苏省守合同重信用企业等,并入选苏州市生物医药产业首批潜力地标培育企业名单和苏州市第三批自主品牌大企业和领军企业先进技术研究院建设企业名单。","listedPrice":7.75},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"江苏吴中(600200)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供江苏吴中(600200)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"江苏吴中,600200,江苏吴中股票,江苏吴中股票老虎,江苏吴中股票老虎国际,江苏吴中行情,江苏吴中股票行情,江苏吴中股价,江苏吴中股市,江苏吴中股票价格,江苏吴中股票交易,江苏吴中股票购买,江苏吴中股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"江苏吴中(600200)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供江苏吴中(600200)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}